← Leaderboards
Kenneth J Soprano
Temple University
$2,729,995
Attributed
$2,729,995
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $263.4K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$2,729,995 · 2
By mechanism
R01$2,729,995 · 2
Top collaborators
No co-investigators on record.
Most similar at Temple University
Same institution · by research overlap
- E Premkumar Reddy$22,814,761
- Shohreh Amini$7,965,987
- Xavier Grana$5,217,972
- Kamel Khalili$43,862,866
- Lopa Mishra$13,709,781
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionTissue /Cell CultureCell Growth RegulationImmunoprecipitationAp1 ProteinRetinoid Binding ProteinsEnzyme InhibitorsCell LineRetinoidsProtein Structure FunctionCell CyclePhosphorylationNeoplastic CellAntineoplasticsOvary NeoplasmsNuclear ReceptorsSquamous Cell CarcinomaRnase Protection AssayCyclinsPolymerase Chain ReactionCyclin Dependent KinaseGel Mobility Shift AssayCrosslinkTranscription Factor
Grant awards (12)
RETINOIDS FOR TREATMENT OF OVARIAN CARCINOMA$249,727
R01 · FY2007 · CA · contact PI
RETINOIDS FOR TREATMENT OF OVARIAN CARCINOMA$257,186
R01 · FY2006 · CA · contact PI
RETINOIDS FOR TREATMENT OF OVARIAN CARCINOMA$263,375
R01 · FY2005 · CA
RETINOIDS FOR TREATMENT OF OVARIAN CARCINOMA$263,375
R01 · FY2004 · CA
Mechanism of Retinoid Inhibition of Oral SCC Cell Growth$209,250
R01 · FY2004 · DE
RETINOIDS FOR TREATMENT OF OVARIAN CARCINOMA$263,375
R01 · FY2003 · CA
Mechanism of Retinoid Inhibition of Oral SCC Cell Growth$209,250
R01 · FY2003 · DE
Mechanism of Retinoid Inhibition of Oral SCC Cell Growth$209,250
R01 · FY2002 · DE
RETINOIDS FOR TREATMENT OF OVARIAN CARCINOMA$204,551
R01 · FY2002 · CA
Mechanism of Retinoid Inhibition of Oral SCC Cell Growth$209,250
R01 · FY2001 · DE
RETINOIDS FOR TREATMENT OF OVARIAN CARCINOMA$198,596
R01 · FY2001 · CA
RETINOIDS FOR TREATMENT OF OVARIAN CARCINOMA$192,810
R01 · FY2000 · CA